Linda Wu
Janssen (United States)(US)Janssen Scientific Affairs (United States)McMaster University(CA)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immune Response and Inflammation, Immunodeficiency and Autoimmune Disorders, Advanced Breast Cancer Therapies
Most-Cited Works
- → IL-12/Th1 and IL-23/Th17 Biliary Microenvironment in Primary Biliary Cirrhosis: Implications for Therapy(2013)207 cited
- → TIM-4 Expressed by Mucosal Dendritic Cells Plays a Critical Role in Food Antigen–Specific Th2 Differentiation and Intestinal Allergy(2007)148 cited
- → Role of caudal in hindgut specification and gastrulation suggests homology between Drosophila amnioproctodeal invagination and vertebrate blastopore(1998)127 cited
- → LL37 and Cationic Peptides Enhance TLR3 Signaling by Viral Double-stranded RNAs(2011)112 cited
- → Mast Cells Play a Crucial Role in Staphylococcus aureus Peptidoglycan-Induced Diarrhea(2007)61 cited
- → Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: The role of TLR2 and NOD2(2007)57 cited
- → Loss of toll-like receptor 3 function improves glucose tolerance and reduces liver steatosis in obese mice(2012)42 cited
- → Real-world prognostic testing and treatment patterns in CLL/SLL: results from 1462 patients in the informCLL registry(2022)13 cited
- → Time to Next Treatment in Patients with Chronic Lymphocytic Leukemia Initiating First-Line Ibrutinib or Acalabrutinib(2023)11 cited
- → Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia(2023)10 cited